Cite
MLA Citation
M Scoto et al.. “G299 Nusinersen (spinraza) is the first drug approved for spinal muscular atrophy (sma): initial experience in patients with sma type 1 treated in the expanded access program (eap).” Archives of disease in childhood, vol. 103, n.d., p. A122. http://access.bl.uk/ark:/81055/vdc_100135539617.0x000057